Table 1 Compound potency (μM, EC50/IC50) and efficacy (% in parenthesis) in FXR-bla, viability and TR-FRET co-activator assays

From: Quantitative High-Throughput Profiling of Environmental Chemicals and Drugs that Modulate Farnesoid X Receptor

Back to article page